Clinical Trials Logo

Post-traumatic; Arthrosis clinical trials

View clinical trials related to Post-traumatic; Arthrosis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03372278 Active, not recruiting - Osteoarthritis, Hip Clinical Trials

PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty

Start date: January 2013
Phase:
Study type: Observational

This study is a multicenter, prospective, non-controlled post market clinical follow-up study. The objectives of this study are to confirm the safety and performance of the commercially available Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty.

NCT ID: NCT03226808 Active, not recruiting - Osteoarthritis Clinical Trials

Vivacit-E Post-market Follow-up Study

Start date: October 1, 2013
Phase: N/A
Study type: Interventional

The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

NCT ID: NCT02679352 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

SMR Stemless Shoulder Arthroplasty Clinical Study

Start date: March 2016
Phase: N/A
Study type: Interventional

Shoulder arthroplasty is a reliable procedure for the treatment of severe shoulder joint diseases to relieve pain and restore shoulder function. Shoulder implants commonly used are characterised by a humeral stem and complications related to the stem are not infrequent. These include: bone stock loss, intraoperative and postoperative break around the implant, malpositioning of the humeral component and difficult eradication of infections inside the bone around the implant. With the aim of reducing stem-related complications, a novel prosthesis characterised by a stem-less design has been developed. The objective of this study is therefore to explore how well people recover after shoulder replacement with this novel stem-less shoulder prosthesis. This will be assessed over 5 years in three different countries in Europe using patient completed questionnaires and clinical and radiographic assessments.